GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: A case-control study

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 7, 2013, Pages 1184-1192

  Matic, Marija ^a,b   Pekmezovic, Tatjana ^a,d   Djukic, Tatjana ^a,b   Mimic Oka, Jasmina ^a,b   Dragicevic, Dejan ^a,c   Krivic, Biljana ^c   Suvakov, Sonja ^a,b   Savic Radojevic, Ana ^a,b   Pljesa Ercegovac, Marija ^a,b   Tulic, Cane ^a,c   Coric, Vesna ^a,b   Simic, Tatjana ^a,b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Institute of Biochemistry   (Serbia)

^c CLINICAL CENTER OF SERBIA   (Serbia)

^d Institute of Epidemiology   (Serbia)

Author keywords

Bladder cancer; Glutathione S transferase (GST); Polymorphism; Smoking

Indexed keywords

GLUTATHIONE TRANSFERASE A1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1;

ADULT; ARTICLE; BLADDER CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENE DELETION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

BLADDER CANCER; GLUTATHIONE S-TRANSFERASE (GST); POLYMORPHISM; SMOKING;

AGED; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 84884667025     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2011.08.005     Document Type: Article

References (59)

1. Sexton W.J., Wiegand L.R., Correa J.J., et al. Bladder cancer: A review of non-muscle-invasive disease. Cancer Control 2010, 17:256-268.
2. Cancer incidence and mortality in Central Serbia 2006, Institute of Public Health of Serbia, Belgrade.
3. Parkin D.M., Bray F., Ferlay J., et al. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
4. Zeegers M.P., Tan F.E., Dorant E., et al. The impact of characteristics of cigarette smoking on urinary tract cancer risk: A meta-analysis of epidemiologic studies. Cancer 2000, 89:630-639.
5. Kellen E., Zeegers M., Paulussen A., et al. Does occupational exposure to PAHs, diesel, and aromatic amines interact with smoking and metabolic genetic polymorphisms to increase the risk on bladder cancer? The Belgian case control study on bladder cancer risk. Cancer Lett 2007, 245:51-60.
6. IARC: Beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans #58 1995, 8-13. World Health Organization, Geneva.
7. McGrath M., Michaud D., De Vivo I. Polymorphisms in GSTT1, GSTM1, NAT1, and NAT2 genes and bladder cancer risk in men and women BMC Cancer 2006, 6:239.
8. Filiadis I., Hrouda D. Genetic factors in chemically-induced transitional cell bladder cancer. BJU Int 2000, 86:794-801.
9. Jung I., Messing E. Molecular mechanisms and pathways in bladder cancer development and progression. Cancer Control 2000, 7:325-334.
10. Simic T., Mimic-Oka J., Savic-Radojevic A., et al. Glutathione S-transferase T1-1 activity up-regulated in transitional cell carcinoma of urinary bladder. Urology 2005, 65:1035-1040.
11. Engel L.S., Taioli E., Pfeiffer R., et al. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: A HuGE review. Am J Epidemiol 2002, 156:95-109.
12. Kim W.J., Kim H., Kim C.H., et al. GSTT1-null genotype is a protective factor against bladder cancer. Urology 2002, 60:913-918.
13. Vineis P. Epidemiology of cancer from exposure to arylamines. Environ Health Perspect 1994, 102:7-10.
14. Hayes J.D., Flanagan J.U., Jowsey I.R. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005, 45:51-88.
15. Hayes J.D., Strange R.C. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000, 61:154-166.
16. Di Pietro G., Magno L.A., Rios-Santos F. Glutathione S-transferases: An overview in cancer research. Expert Opin Drug Metab Toxicol 2010, 6:153-170.
17. Eaton D.L., Bammler T.K. Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci 1999, 49:156-164.
18. Landi S. Mammalian class θ GST and differential susceptibility to carcinogens: A review. Mutat Res 2000, 463:247-283.
19. Ali-Osman F., Akande O., Antoun G., et al. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants: Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 1997, 272:10004-10012.
20. Watson M.A., Stewart R.K., Smith G.B., et al. Human glutathione S-transferase P1 polymorphisms: Relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998, 19:275-280.
21. Hu X., O'Donnell R., Srivastava S.K., et al. Active site architecture of polymorphic forms of human glutathione S-transferaseP1-1 accounts for their enantioselectivity and disparate activity in the glutathione conjugation of 7,8-dihydroxy-9, 10-oxy-7,8,9,10-tetrahydrobenzo (a) pyrene. Biochem Biophys Res Commun 1997, 235:424-428.
22. Sundberg K., Johansson A.S., Stenberg G., et al. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 1998, 19:433-436.
23. Coles B.F., Morel F., Rauch C., et al. Effect of polymorphism in the human glutathione S-transferase A1 (hGSTA1) promoter on hepatic GSTA1 and GSTA2 expression. Pharmacogenetics 2001, 11:663-669.
24. Coles F.B., Kadlubar F.F. Human α class glutathione S-transferases: Genetic polymorphism, expression, and susceptibility to disease. Glutathione Transferases and γ-Glutamyl Transpeptidases, Methods Enzymology 2005, 9-42. Elsevier Academic Press, London. S. Helmut, P. Lester (Eds.).
25. Garcia-Closas M., Malats N., Silverman D., et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: Results from the Spanish Bladder Cancer Study and meta-analyses Lancet 2005, 366:649-659.
26. Johns L.E., Houlston R.S. Glutathione S-transferase μ1 (GSTM1) status and bladder cancer risk: A meta-analysis. Mutagenesis 2000, 15:399-404.
27. McGrath M., Michaud D., De Vivo I. Polymorphisms in GSTT1, GSTM1, NAT1, and NAT2 genes and bladder cancer risk in men and women BMC Cancer 2006, 6:239.
28. Hung R.J., Boffetta P., Brennan P., et al. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures, and bladder cancer risk in a high-risk population. Int J Cancer 2004, 110:598-604.
29. Karagas M.R., Park S., Warren A., et al. Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: A population-based study. Cancer Lett 2005, 219:63-69.
30. Lee S.J., Cho S.H., Park S.K., et al. Combined effect of glutathione S-transferase M1 and T1 genotypes on bladder cancer risk. Cancer Lett 2002, 177:173-179.
31. Salagovic J., Kalina I., Habalova V., et al. The role of human glutathione S-transferases M1 and T1 in individual susceptibility to bladder cancer. Physiol Res 1999, 48:465-471.
32. Ma Q.W., Lin G.F., Chen J.G., et al. Polymorphism of glutathione S-transferase T1, M1, and P1 genes in a Shanghai population: Patients with occupational or non-occupational bladder cancer. Biomed Environ Sci 2002, 15:253-260.
33. Giannakopoulos X., Charalabopoulos K., Baltogiannis D., et al. The role of N-acetyltransferase-2 and glutathione S-transferase on the risk and aggressiveness of bladder cancer. Anticancer Res 2002, 22:3801-3804.
34. Brockmoller J., Cascorbi I., Kerb R., Roots I. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 1996, 56:3915-3925.
35. Kempkes M., Golka K., Reich S., et al. Glutathione S-transferase GSTM1 and GSTT1 null genotypes as potential risk factors for urothelial cancer of the bladder. Arch Toxicol 1996, 71:123-126.
36. Simic T., Savic-Radojevic A., Pljesa-Ercegovac M., et al. Glutathione S-transferases in kidney and urinary bladder tumors. J Nat Rev Urol 2009, 6:281-289.
37. Zeng F.F., Liu S.Y., Wei W., et al. Genetic polymorphisms of glutathione S-transferase T1 and bladder cancer risk: A meta-analysis. Clin Exp Med 2010, 10:59-68.
38. Kellen E., Hemelt M., Broberg K., et al. Pooled analysis and meta-analysis of the glutathione S-transferase P1 Ile 105Val polymorphism and bladder cancer: A HuGE-GSEC review. Am J Epidemiol 2007, 165:1221-1230.
39. Bell D.A., Taylor J.A., Paulson D.F., et al. Genetic risk and carcinogen exposure: A common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993, 85:1159-1164.
40. Lafuente A., Zakahary M.M., el-Aziz M.A., et al. Influence of smoking in the glutathione-S-transferase M1 deficiency-associated risk for squamous cell carcinoma of the bladder in schistosomiasis patients in Egypt. Br J Cancer 1996, 74:836-838.
41. Cao W., Cai L., Rao J.Y., et al. Tobacco smoking, GSTP1 polymorphism, and bladder carcinoma. Cancer 2005, 104:2400-2408.
42. Komiya Y., Tsukino H., Nakao H., et al. Human glutathion S-transferase A1 polymorphism and susceptibility to urothelial cancer in the Japanese population. Cancer Lett 2005, 221:55-59.
43. Garcia-Closas M., Kelsey K.T., Hankinson S.E., et al. Glutathione S-transferase μ and θ polymorphisms and breast cancer susceptibility. J Natl Cancer Inst 1999, 91:1960-1964.
44. Pemble S.E., Taylor J.B. An evolutionary perspective on glutathione transferases inferred from class-θ glutathione transferase cDNA sequences. Biochem J 1992, 287:957-963.
45. Harries L.W., Stubbins M.J., Forman D., et al. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular, and prostate cancer. Carcinogenesis 1997, 18:641-644.
46. Habdous M., Siest G., Herbeth B., et al. Glutathione S-transferases genetic polymorphisms and human diseases: Overview of epidemiologic studies. Ann Biol Clin (Paris) 2004, 62:15-24.
47. Golka K., Schmidt T., Seidel T., et al. The influence of polymorphisms of glutathione S-transferases M1 and M3 on the development of human urothelial cancer. J Toxicol Environ Health A 2008, 71:881-886.
48. Yuan J.M., Chan K.K., Coetzee G.A., et al. Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer. Carcinogenesis 2008, 29:1386-1393.
49. Mittal R.D., Srivastava D.S., Mandhani A., et al. Genetic polymorphism of drug metabolizing enzymes (CYP2E1, GSTP1) and susceptibility to bladder cancer in North India. Asian Pac J Cancer Prev 2005, 6:6-9.
50. Sweeney C., Coles B.F., Nowell S., et al. Novel markers of susceptibility to carcinogens in diet: Associations with colorectal cancer. Toxicology 2002, 181/182:83-87.
51. Van der Logt E.M., Bergevoet S.M., Roelofs H.M., et al. Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk. Carcinogenesis 2004, 25:2407-2415.
52. Ning B., Wang C., Morel F., et al. Human glutathione S-transferase A2 polymorphisms: Variant expression, distribution in prostate cancer cases/controls, and a novel form. Pharmacogenetics 2004, 14:35-44.
53. McGlynn K.A., Hunter K., LeVoyer T., et al. Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans. Cancer Res 2003, 63:4594-4601.
54. McCarty K.M., Santella R.M., Steck S.E., et al. PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk. Environ Health Perspect 2009, 117:552-558.
55. Oniki K., Umemoto Y., Nagata R., et al. Glutathione S-transferase A1 polymorphism as a risk factor for smoking-related type 2 diabetes among Japanese. Toxicol Lett 2008, 178:143-145.
56. Savic-Radojevic A., Mimic-Oka J., Pljesa-Ercegovac M., et al. Glutathione S-transferase-P1 expression correlates with increased antioxidant capacity in transitional cell carcinoma of the urinary bladder. Eur Urol 2007, 52:470-477.
57. Rossi A.M., Guarnieri C., Rovesti S., et al. Genetic polymorphisms influence variability in benzene metabolism in humans. Pharmacogenetics 1999, 9:445-451.
58. Ahn J., Gammon M.D., Santella R.M., et al. Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk. Carcinogenesis 2006, 27:1876-1882.
59. Palma S., Cornetta T., Padua L., et al. Influence of glutathione S-transferase polymorphisms on genotoxic effects induced by tobacco smoke. Mutat Res 2007, 633:1-12.